Aline Seifert, born in 1974, graduated from the Otto Friedrich University in Bamberg with a major in Finance in 2002. She started her professional career in 2003 at Novartis Pharma in Nuremberg as a Financial Analyst with a focus on Marketing & Sales.
In 2004 she joined Novartis subsidiary Sandoz Pharmaceuticals in Ismaning as Head of Finance and Administration and member of the German Management Board. In 2006 she was given regional responsibility as Head of Business Planning & Analysis Nordics at Sandoz A/S in Odense/Denmark. There she was responsible for all four Scandinavian countries in the finance function.
From 2008 until the end of 2013, she held positions with global orientation and responsibility at Sandoz International in Holzkirchen without exception, most recently as Global Head of Strategic Quality Projects.
At the end of 2013, Mrs Seifert was recruited as Finance Director by the dynamically growing Belgian OTC company Omega Pharma and was appointed General Manager of Omega Pharma Deutschland in Herrenberg, now part of the global Perrigo Group, in September 2016 due to her convincing success.
On October 1st 2017, she began her work as Director of Finance and IT and member of the Executive Board of Alliance Healthcare Deutschland AG. Effective July 5, 2018, the Supervisory Board appointed Ms. Seifert to the Management Board.
Since April 1st 2019, she has taken over as CEO of the German Management Board of the company, replacing Wolfgang Mähr, who is returning to the Supervisory Board as Chairman.
Member of the Board
Marco is the General Counsel for WBA's International business, which is composed of the company's global Pharmaceutical Wholesale business, international Retail Pharmaceutical business (excluding UK & Ireland) as well as the Global Consumer Brands division.
Prior to joining WBA in September 2018, Marco held senior leadership positions at L'Oreal, Ralph Lauren and Procter & Gamble. Marco specializes in corporate, licensing and transactional matters. Marco is a member of the New York State Bar and is also admitted as a solicitor in United Kingdom. He is active in various professional organizations, and is a frequent guest speaker at seminars and conferences on corporate transactions and intellectual property topics.
On June 24th 2019, Marco Kerschen was appointed interim member of the Management Board of Alliance Healthcare Deutschland AG by the Supervisory Board of Alliance Healthcare Deutschland AG.